• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Mirati - oncology?

ab0281b0-a143-4e12-97d5-5a97b9dbf5b5_medium.png

All your base are belong to us

He looks a lot more inflamed with dermatitis these days. Too much gluten in his porky diet along with the toxic culture of Mirati.